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Abstract
Genome-Wide Association studies (GWAS) of both Crohn’s Disease (CD) and Ulcerative Colitis (UC) have unearthed over 40
risk conferring variants. Recently, a meta-analysis on UC revealed several loci, most of which were either previously
associated with UC or CD susceptibility in populations of European origin. In this study, we attempted to replicate these
findings in an ethnically distinct north Indian UC cohort. 648 UC cases and 850 controls were genotyped using Infinium
Human 660W-quad. Out of 59 meta-analysis index SNPs, six were not in the SNP array used in the study. Of the remaining 53
SNPs, four were found monomorphic. Association (p,0.05) at 25 SNPs was observed, of which 15 were CD specific. Only five
SNPs namely rs2395185 (HLA-DRA), rs3024505 (IL10), rs6426833 (RNF186), rs3763313 (BTNL2) and rs2066843 (NOD2) retained
significance after Bonferroni correction. These results (i) reveal limited replication of Caucasian based meta-analysis results;
(ii) reiterate overlapping molecular mechanism(s) in UC and CD; (iii) indicate differences in genetic architecture between
populations; and (iv) suggest that resources such as HapMap need to be extended to cover diverse ethnic populations. They
also suggest a systematic GWAS in this terrain may be insightful for identifying population specific IBD risk conferring loci
and thus enable cross-ethnicity fine mapping of disease loci.
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Introduction
Ulcerative colitis (UC) and Crohn’s disease (CD), the two sub-
phenotypes of inflammatory bowel diseases (IBDs), are polygenic
conditions that are suspected to result from dysregulated activation
of immune mechansism to commensal microbes in genetically
predisposed individuals. Considered to be a disease of the
developed populations, there is growing evidence that the
incidence of the disease may be high in developing countries as
well. This is more so for ethnically heterogeneous populations such
as the north Indian population, where we have recently shown that
the incidence of disease in particular for UC is comparable to that
reported in Western countries [1].
It is well established that genetic factors contribute to
susceptibility for both CD and UC. Recently Genome wide
association studies (GWAS) together with meta-analysis of GWAS
findings involving UC [2–7] and CD [8–12] unearthed several risk
conferring loci. Although some loci showed specific association
with CD (ATG16L1) [10] or UC (IL10, ECM1, HERC2) [13], a
substantial overlap in genetic risk factors between the phenotypes
have also been observed with genes such as IL23R at the forefront
[6,14–15]. Discovery of these susceptibility genes, common as well
as unique, has provided valuable insights into the link between the
innate and adaptive immunity vis-a `-vis risk for IBD.
Most candidate gene studies and recent GWAS have confirmed
absence of associations with susceptibility variants in NOD2 gene
and UC in Caucasians. However, we have previously reported
notable allelic heterogeneity in this gene in a UC cohort from north
India wherein the three frequently CD associated variants namely
rs2066844, rs2066845 and rs2066847 were either absent or rarely
present. Upon re-sequencing the gene in control subjects, only two
reported polymorphisms, rs2066842 (Pro268Ser) and rs2067085
(Ser178Ser) were found. Of these, Pro268Ser that is common in
Caucasians but associated with CD only in the presence of SNP13
was significantly associated with UC in our cohort. Analyzing the
tag SNP profile for NOD2 locus in this population revealed that the
LD structure around Pro268Ser in the north Indians differs from
that among Caucasians. These novel findings suggest population
specific genetic profiles for UC in the north Indian population [16]
warranting replication of other promising candidate genes.
With this background, we investigated whether the UC/CD
genes/loci reported in the recent meta-analyses [6] were associated
with UC in the ethnically distinct north Indian population.
Results
Six of the 59 meta-analysis index SNPs were not present in the
Infinium Human 660W-quad array used in this study (Table 1).
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rs11209026 (IL23R); rs2476601 (PTPN22) and rs4613763
(LOC730002) were monomorphic and therefore additional SNPs
from these genes/loci were tested. Barring IL23R, both PTPN22
and LOC730002 were not significant (p.0.05) in our cohort. The
associated IL23R SNPs are shown in Table 2.
Of the remaining 49 index SNPs, associations were replicated
with 25 SNPs (p,0.05) with 15 of them previously identified as CD
specific (including rs2188962 located in IBD5 locus) (Table 1).
Among these, five SNPs namely rs6426833 (RNF186, p=0.0004),
rs3024505 (IL10, p=0.001), rs3763313 (BTNL2, p=2.415e
205),
rs2395185 (HLA-DRA, p=2.038e
206) and rs2066843 (NOD2,
p=0.0002) withstood Bonferroni correction (Table 1, Fig. 1). It is
noteworthy to mention here that we previously reported association
of Pro268Ser in NOD2, a famous CD specific gene, [16] which is in
complete LD (r
2=1) with aforementioned SNP rs2066843.
While loci harbouring ITLN1 and CCL2, both reported as CD
specific genes showed borderline significance p=0.07 and 0.06
respectively, other notable functional genes/ loci such as CARD9,
IL26, IL12B, CEP72, PUS10, FCGR2A, KIF21B, CDKAL1 and
MAP3K7IP2 otherwise replicated in Caucasians were not
significantly associated with UC in north Indians (Table 1).
Interestingly, another promising CD associated candidate,
ATG16L1, also showed modest association (p=0.05) in our
sample. With about 650 cases/850 controls and after accounting
for 49 comparisons (alpha set at 0.001), the study had sufficient
power (80% using QUANTO http://hydra.usc.edu) to detect
associations with odds ratios 1.3 or higher (or 0.77 or lower) for
allele frequencies between 20%,30%, odds ratios 1.4 or higher
(0.71 or lower) for allele frequencies between 10%–20% & odds
ratios 1.6 or higher for allele frequencies of 5,10% assuming a
log-additive model of inheritance.
Discussion
Recent GWAS have identified .30 susceptibility genes/loci that
predispose populations of European origin to IBD. The credibility
and relevance of these genetic association studies is indicated by the
successof replicationattempts indiverseethnicgroups.Thus, in this
study we investigated the contribution of these IBD specific loci in
our ethnically heterogeneous north Indian UC cohort in order to
define its genetic architecture more conclusively.
Our study showed that SNPs from IL23R, PTPN22 and
LOC730002/PTGER4 were largely monomorphic in our cohort.
Though additional SNPs from in and around PTPN22 and
LOC730002 did not show any association with UC, findings from
IL23R locus (Table 2) warrant discussion. IL23R is considered as a
genuine ‘‘generic’’ IBD susceptibility gene and has attained
genome-wide significance with both UC [4,9,18–20] and CD
[9,19,21–22] in various GWAS and independent replication
studies. Interestingly, the non-synonymous SNP (rs11209026),
the most widely replicated marker, with a potential protective role
in Caucasians [9,19,23] and rs11465804 were almost monomor-
phic in both UC cases and controls. However, significant
association (p,0.05) of additional SNPs selected from both within
and around this gene (Table 2) is strongly suggestive of IL23R
being a potential susceptibility gene and therapeutic target for UC
in the north Indian population as well. However, the strength of
association of this gene may vary in different populations. It may
be mentioned here that resequencing of the complete IL23R
exonic regions in 30 north Indian population based controls did
not reveal any exonic SNPs in this gene. Thus, the suggestive
association of SNPs around this gene (Table 2) may indicate the
role of regulatory variants in IL23R in UC etiology in our cohort.
Alternatively, the associated SNP may be in linkage disequilibrium
with another yet undetected causal variant. These results also
demonstrate the importance of normative allelic data for
populations under investigation while selecting SNPs for replica-
tion of association findings in them. Absence of IL23R SNPs
(rs11465804 and rs11209026) has also been reported in Japanese,
Korean and Chinese cohorts [7,24–26]. Such a fluctuation in
allele frequencies across geographic regions could be attributed to
different environmental conditions leading to apparent genetic/
allelic heterogeneity of disease between Asians and Caucasians.
An enticing highlight of this study is that we could replicate a
few previously acknowledged UC specific SNPs in or near genes/
loci such as RNF186, IL10, DLD, and NKX2-3 with HLA-DRA
leading the list (Table 1). The anti-inflammatory cytokine IL10 has
long been proposed to limit intestinal inflammation, and
genetically engineered IL-10 deficient mice develop spontaneous
colitis suggesting it might serve as a therapeutic target for UC [27].
NKX2-3, association of which has previously been shown with
CD, is a transcription factor gene found to be associated with UC
among Caucasians [6] seems to be a generic IBD gene in our
sample also. Reassessment of such potential regions in both
Caucasian and north Indian populations, who are ethnically
related to Caucasian stock [28] may illuminate the common key
pathogenic pathways underlying UC.
It has been reported that there exists an excess clustering of both
CD and UC in families, which underscores the concept that the
genetic architecture of these two disorders are overlapping. Of the
49 informative index SNPs tested in our UC cohort, 17 have been
previously reported to be CD specific (Table 1). Of these, observed
association of functionally relevant CD loci such as JAK2,
IL18RAP, LYRM4, TRIB1, TNFSF15, ZPBP2 with BTNL2
and NOD2 at the forefront is noteworthy (Table 1). Recent
investigation has shown an association between BTNL2 gene and
UC in population of European and Asian descent [29–30]. Both in
our previous [16] and this study we observed association of NOD2
with UC in the north Indian cohort suggesting the ethnic-
specificity of this gene. Further, to investigate its possible
contribution to CD, extensive resequencing in our CD cohort
(N=50) was carried out. Similar to UC, absence of SNPs 8, 12
and 13 and occurrence of Pro268Ser indicated that allelic
heterogeneity with regards to NOD2 may be at play for CD as
well. It has been reported that SNPs 8, 12 and 13 represent 82% of
the NOD2-mutated chromosomes, [31] and that these polymor-
phisms account for about 18% of the genetic risk of CD in the
Caucasian population [32]. Thus, our findings reiterate population
specific genetic susceptibilities underlying complex disorders such
as IBD which is a pathogen driven condition. These observations
were corroborated by ATG16L1 (p=0.05) (Table 1) further
support that population specific disease susceptibility genes exist
for IBD. Additionally, FCGR2A-FCGR2C region which reached
genome-wide significance in both Japanese and Caucasian cohorts
[6–7] was not significant in our population (Table 1). Similar
findings have also been reported for TNFSF-15 wherein the
variants strongly associated with Caucasian UC cohort were not
significant in Japanese UC samples [33].
To summarize, our replication attempt of meta-analysis findings
clearly reveal (a) partial concordance of Caucasian based meta-
analysis results; and (b) apparent genetic/ allelic heterogeneity at
UC/CD loci. It is likely that some SNPs that did not pass
correction may be associated with UC in north Indians but the
study did not have sufficient power to detect these associations. In
conclusion, the observed disparity in the allele frequency of
GWAS hits in our cohort confirms differences in genetic
architecture between populations. These results also suggest that
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phenotype in caucasians P-value Allele OR
rs1317209 1 RNF186 UC 0.62
rs3806308 1 RNF186 UC 0.008* A 0.80
rs6426833 1 RNF186 UC 0.0004** G 0.74
rs2201841 1 IL23R UC 0.044* A 0.85
rs11465804
b 1 IL23R CD -
rs11209026
b 1 IL23R UC -
rs2476601
b 1P T P N 2 2 C D -
rs2274910 1 ITLN1 CD 0.08
rs10800309 1 FCGR2A UC 0.40
rs9286879 1 LOC441915 CD 0.15
rs3024505 1 IL10 UC 0.001** A 1.41
rs11584383 1 KIF21B CD 0.41
rs780094 2 GCKR CD 0.027* A 1.21
rs6706689 2 PUS10 UC 0.33
rs13003464 2 PUS10 IBD 0.68
rs917997 2 IL18RAP CD 0.006* A 1.23
rs3828309 2 ATG16L1 CD 0.06
rs3197999 3 MST1 IBD 0.027* A 1.21
rs4957048 5 CEP72 UC 0.65
rs4613763
b 5 LOC730002 CD -
rs2188962 5 LOC441108 CD 0.028* A 1.27
rs10045431 5 IL12B CD 0.33
rs13361189
c 5 IRGM CD -
rs12529198 6 LYRM4 CD 0.020* G 0.80
rs6908425 6 CDKAL1 CD 0.90
rs3763313 6 BTNL2 CD 0.00002** C 0.56
rs2395185 6 HLA-DRA UC 0.000002** A 0.63
rs7758080 6 MAP3K7IP2 CD 0.32
rs2301436 6 FGFR1OP CD 0.047* A 1.17
rs7746082 6 PRDM1 CD 0.019* A 1.24
rs17309827
c 6 SLC22A23 CD -
rs1456893 7 ZPBP CD 0.12
rs4598195 7 DLD UC 0.005* C 0.78
rs1551398 8 TRIB1 CD 0.004* A 1.24
rs10758669 9 JAK2 CD 0.008* C 1.22
rs4077515 9 CARD9 UC 0.16
rs4263839 9 TNFSF15 CD 0.019* A 0.81
rs11190140 10 NKX2-3 IBD 0.006* A 1.23
rs17582416 10 CUL2 CD 0.14
rs10995271 10 ZNF365 CD 0.43
rs7927894 11 C11orf29 CD 0.09
rs1558744 12 LOC341333 UC 0.31
rs971545 12 IL26 UC 0.73
rs11175593
c 12 LRRK2,MUC19 CD -
rs3764147 13 C13orf31 CD 0.282
rs2066843 16 NOD2 CD 0.0002** A 1.46
rs2066844
c 16 CARD15 CD -
rs2066845
c 16 CARD15 CD -
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ethnic populations within the Indian subcontinent in order to
enhance their utility for the conduct of association studies within
these heterogeneous populations. Further, as the current study was
limited to a selection of SNPs identified as susceptibility markers
from the recent UC specific meta-analysis, a systematic GWAS in
this terrain may not only be insightful for identifying population
specific IBD risk conferring loci but also enable cross-ethnicity fine
mapping of disease loci. Collectively, these data may help define
the genetic relationship between CD and UC and thus unravel




Ethical approval for this study was given by the respective
institutional ethical committees (IEC, DMCH and IEC, UDSC)
and informed written consent was acquired from the participants.
UC and control subjects
A case-control study was carried out in subjects recruited from a
tertiary hospital in Punjab, India. In brief, the diagnosis of UC was
based on standard criteria that included clinical, endoscopic,
radiologic and histopathological criteria. Patients with infectious
colitis and indeterminate colitis were excluded. Controls were
individuals recruited from the same study hospital and included
blood donors and patients diagnosed with other ailments not
related to IBD. Controls were selected such that they were
ethnically similar to the cases and whose age range (610 years)
was within that of the cases.
DNA extraction and Genotyping
DNA was collected from peripheral blood samples of UC
patients and control samples using conventional phenol-chloro-
form method. For replicating meta-analysis based associations,
648 cases and 850 controls were genotyped using Infinium Human
660W-quad. Quality control steps were applied before the SNP
genotypes were included in the final analysis. The average
genotyping success rate was 99% and no marker deviated
significantly (P,0.0001) from Hardy–Weinberg equilibrium in
controls. In addition, SNPs with a minor allele frequency
(MAF),0.05 and missingness rate .0.05 were excluded. SNPs
were tested for association with UC by Chi-square test
implemented in PLINK [16] and Bonferroni correction was also
applied.
Resequencing
Exonic and exon-intron boundary regions of both NOD2 and







phenotype in caucasians P-value Allele OR
rs2066847
c 16 CARD15 CD -
rs2872507 17 ZPBP2 CD 0.009* A 1.22
rs2305480 17 GSDML UC 0.011* A 1.21
rs744166 17 STAT3 CD 0.047* G 0.86
rs991804 17 CCL2 CD 0.06
rs8098673 18 LOC728473 CD 0.038* C 0.85
rs2542151 18 PTPN2 CD 0.041* G 1.21
rs4807569 19 SBNO2 CD 0.53
rs2836878 21 LOC391282 UC 0.011* A 0.79
rs762421 21 ICOSLG CD 0.09
rs1736135 21 LOC388814 CD 0.85
aMc Govern, et al., Genome-wide association identifies multiple ulcerative colitis susceptibility loci (2010) Nat Genet.; 42(4):332–7.
bMonomorphic.
cSNPs not in the Illumina Human600W-Quad used in this study.
*p,0.05.
**Significant after Bonferroni correction.
doi:10.1371/journal.pone.0016565.t001
Table 1. Cont.
Table 2. List of significant (p,0.05) SNPs in and around IL23R
gene.
SNP Allele P-value OR (95% Confidence Intervals)
rs10889657 G 0.005 0.79 (0.67–0.95)
rs1884444 C 0.01 0.83 (0.70–0.96)
rs2064689 A 0.01 0.81 (0.69–0.97)
rs10489630 C 0.02 0.83 (0.71–0.98)
rs1004819 G 0.04 0.86 (0.72–0.97)
rs7517847 C 0.004 0.79 (0.67–0.94)
rs6682033 G 0.01 0.76 (0.62–0.96)
rs1343151 A 0.01 0.77 (0.61–0.93)
rs11209032 G 0.02 0.84 (0.70–0.94)
rs1495965 A 0.03 0.85 (0.71–0.96)
rs3790562 G 0.02 0.69 (0.51–0.95)
rs3790565 G 0.01 0.76 (0.63–0.99)
rs4297265 G 0.04 0.86 (0.75–1.02)
rs2270614 A 0.04 0.86 (0.75–1.02)
rs7555183 A 0.02 0.84 (0.75–1.03)
doi:10.1371/journal.pone.0016565.t002
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exons are available on request.
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